[Pubmed] Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient-Reported Me

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6507
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    unknown  AhrefsSiteAudit/6.1

[Pubmed] Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient-Reported Me

Message par RSS-Bot »


Ann Clin Transl Neurol. 2025 Nov 19. doi: 10.1002/acn3.70257. Online ahead of print.

ABSTRACT

BACKGROUND: Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life-threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data.

METHODS: In this 12-week randomized controlled study, 30 MG patients recorded symptoms using patient-reported outcome measures (PROMs) and patient-performed measures via a mobile app, alongside data from wearables. MG deterioration was defined as a ≥ 3-point worsening in the Quantitative Myasthenia Gravis score, occurrence of MG-related hospitalization or exacerbation. A machine learning linear classifier was trained to predict deterioration and cross-validated. The area under the receiver operator characteristic curve (AUROC) was calculated, accepting 1-2 false alarms (FAs) per week.

RESULTS: The model achieved the best predictive performance when using all input signals (AUROC 0.85 (95% confidence interval 0.77-0.91)) and remained stable across look-back windows of 4-10 days. Model sensitivity was 0.65 (0.48-0.83) to 0.82 (0.60-1.00) (1 and 2 FAs per week, respectively). PROMs reflected worsening symptoms before deterioration; wearables alone showed higher AUROCs.

INTERPRETATION: Multimodal self-monitoring via MyaLink predicted MG deterioration with good performance at acceptable FA rates. This approach may enable earlier clinical interventions of MG worsening.

TRIAL REGISTRATION: The study was registered under the German Clinical Trial Registry (DRKS00029907).

PMID:41261388 | DOI:10.1002/acn3.70257


Source: https://pubmed.ncbi.nlm.nih.gov/4126138 ... 22+67771e2
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »